ArticleFrontiers in sports and active living2025
Effective anti-doping testing program during major sport events: a comparative analysis of two multi-sport tournaments held in Poland in 2017 and 2023.
Article in Frontiers in sports and active living, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Major Sporting Events (MSEs), particularly Multi-Sport Tournaments (MSTs), present significant logistical and operational challenges in the implementation of effective Anti-Doping Programs (ADPs). This study presents a comparative analysis of ADP implementation during two MSTs hosted in Poland: The World Games 2017 (TWG 2017) and the European Games 2023 (EG 2023). Methods: The analysis encompasses organizational logistics, sample collection processes, laboratory testing, and the broader implications for national anti-doping activities conducted by the Polish Anti-Doping Agency (POLADA) and the Polish Anti-Doping Laboratory (PLAD), which in 2017 operated under the name Department of Anti-Doping Research at the Institute of Sport. Results: TWG 2017 involved 3,292 athletes, whereas EG 2023 hosted 6,380 participants. Although both events utilized the same number of sport venues, the wider geographical distribution of EG 2023 introduced greater logistical complexity. The number of Sample Collection Personnel (SCP) increased in absolute terms for EG 2023, comprising 90 Doping Control Officers (DCO) and 120 chaperones, in contrast to 37 DCOs and 35 chaperones during TWG 2017. However, when adjusted to the number of athletes, the increase was not statistically significant. This rise in SCP corresponded to a significant increase in testing volume: 1,210 samples were collected at EG 2023 compared to 401 at TWG 2017, with a notably higher proportion of out-of-competition tests. Both MSTs placed considerable demands on the routine operations of POLADA and PLAD. Discussion: Despite structural similarities and the involvement of shared institutional stakeholders, EG 2023 represented a significant scale-up in ADP due to the increased number of athletes, greater geographical dispersion, and enhanced testing complexity. These findings underscore the necessity for scalable, context-specific and coordinated anti-doping strategies. These need to be tailored to the unique operational demands of MSTs, distinguishing them from single-sport events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.